Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment (2022)
- Authors:
- USP affiliated authors: ISHIDA, KELLY - ICB ; WIRTH, FERNANDA - ICB
- Unidade: ICB
- DOI: 10.2217/fmb-2021-0291
- Subjects: MICROBIOLOGIA; CIÊNCIA DA COMPUTAÇÃO; ANTIFÚNGICOS; CRIPTOCOCOSE; MODELOS ANIMAIS; FARMACODINÂMICA; MICOSES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Microbiology
- ISSN: 1746-0921
- Volume/Número/Paginação/Ano: p. 1-14, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WIRTH, Fernanda et al. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment. Future Microbiology, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.2217/fmb-2021-0291. Acesso em: 11 fev. 2026. -
APA
Wirth, F., Staudt, K. J., Araújo, B. V., & Ishida, K. (2022). Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment. Future Microbiology, 1-14. doi:10.2217/fmb-2021-0291 -
NLM
Wirth F, Staudt KJ, Araújo BV, Ishida K. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment [Internet]. Future Microbiology. 2022 ; 1-14.[citado 2026 fev. 11 ] Available from: https://doi.org/10.2217/fmb-2021-0291 -
Vancouver
Wirth F, Staudt KJ, Araújo BV, Ishida K. Experimental models for pharmacokinetic and pharmacodynamic studies of antifungals used in cryptococcosis treatment [Internet]. Future Microbiology. 2022 ; 1-14.[citado 2026 fev. 11 ] Available from: https://doi.org/10.2217/fmb-2021-0291 - Three-dimensional lung parenchyma model for studies of aspergillus fumigatusinfection and antifungal treatment
- Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms
- Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis
- Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole
- Characterization of Candida spp. isolated from vaginal fluid: identification, antifungal susceptibility, and virulence profile
- Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis
- Δ(24)-sterol methyltransferase plays an important role in the growth and development of Sporothrix schenckii and Sporothrix brasiliensis
- Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil
- Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses
- Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine
Informações sobre o DOI: 10.2217/fmb-2021-0291 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
